Skip to main content
. 2024 Jul 18;24:175. doi: 10.1186/s12880-024-01350-0

Table 1.

Baseline characteristics of patients with PHEOs and non-PHEOs

PHEO(n = 35) non-PHEO(n = 27) P value
Age(years) 49.8 ± 14.42 57.2 ± 9.80 0.024*
Gender
 Men 20(57.1%) 13(48.1%) 0.482▾
 Women 15(42.9%) 14(51.9%)
Weight(kg) 62.63 ± 12.80 66.50 ± 9.24 0.190*
BMI (kg/m2) 22.56 ± 3.18 24.98 ± 2.80 0.619*
Hypertension 21(60.0%) 22(81.5%) 0.069▾
Diabetes 7(20%) 5(18.5%) 0.884▾
Cerebrovascular events 2(5.7%) 3(11.1%) 0.762▾
Cardiovascular events 2(5.7%) 1(3.7%) 1.000▾
LD(mm) 39.83 ± 19.23 24.19 ± 9.43 0.001*
SD(mm) 32.03 ± 13.71 21.19 ± 8.69 0.002*
LD/SD 1.24 ± 0.25 1.25 ± 0.0.15 0.900*
Laterality
 Left 16(45.7%) 17(63%) 0.177▾
 Right 19(54.3%) 10(37%)

Numbers of patients in each group are indicated in brackets. *Data are means ± standard deviation, and the statistical values are the independent sample t-test results▾Data in parentheses are percentages, and the statistical values are the chi-square test results. PHEOs, pheochromocytomas. non-PHEOs, non- pheochromocytomas